Drugs News and Research

RSS

Non-invasive treatment shows early promise for vestibular migraine attacks

There may be some good news for people with vestibular migraine, a type of migraine that causes vertigo and dizziness with or without headache pain.

26 Sep 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Web-based, digital-app birth control prescription services appear to be overall safe and efficient

Web-based and digital-app services that offer oral contraception appear to be overall safe and efficient, according to the findings of a secret-shopper-style study conducted by researchers at Harvard Medical School and UC Davis that analyzed the birth control prescription services of nine U.S. vendors.

26 Sep 2019

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama is home to one of the most exciting studies underway in pediatric cancer: evaluating the use of a cold sore virus to treat children with progressive malignant brain tumors.

26 Sep 2019

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

26 Sep 2019

Arthritis drug could be used to treat lichen planus skin rash

Constant itchy, painful bumps, scaly arms and legs, and damaged nails make lichen planus an inflammatory skin disease that's both frustrating and painful for patients trying to keep their quality of life.

26 Sep 2019

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa.

26 Sep 2019

New discovery sheds light on how pancreatic cancer fuels its growth

A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work - and for whom they will fail.

26 Sep 2019

KHN’s ‘What the Health?’: Impeachment and the health agenda

How will the impeachment effort on Capitol Hill affect work on other legislation, particularly bills to restrain the cost of prescription drugs and surprise medical bills? And will Congress and President Donald Trump be able to agree on the spending bills needed to keep the federal government open for business?

26 Sep 2019

Russian researchers come up with faster method to discover antibiotics

Russian biochemists have identified a promising new class of antibiotics. Having studied over 125,000 molecules, they found that 2-pyrazol-1-yl-thiazole derivatives exhibit antibacterial properties.

26 Sep 2019

Research reveals molecular link between chronic pain and depression

Researchers at Hokkaido University have identified the brain mechanism linking chronic pain and depression in rats. Their research, which was recently published in The Journal of Neuroscience, could lead to the development of new treatments for chronic pain and depression.

26 Sep 2019

'A new era of drug discovery’: Company develops drug using AI

For the first time, a company has discovered a drug target and corresponding candidate using artificial intelligence (AI).

26 Sep 2019

Volatile substances inhaled during chroming may ‘dissolve the brain’

Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.

26 Sep 2019

AI technique helps detect people at risk of heart failure

Researchers have recently used an artificial intelligence (AL) technique to examine how MRI scans can validate how hereditary factors can impact heart function.

26 Sep 2019

NanoSurface Biomedical expands stem cell-based technologies with acquisition of Silene Biotech

Seattle biotech company NanoSurface Biomedical, Inc., a leading provider of biomimetic cell-based assay platforms and services, announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services.

From Curi Bio 26 Sep 2019